Champions Oncology Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Cash & Equivalents	4.87	9.79	2.62	10.12	9.01
Cash & Short-Term Investments	4.87	9.79	2.62	10.12	9.01
Cash Growth	-50.21%	273.76%	-74.13%	12.34%	92.17%
Accounts Receivable	13.18	11.2	9.53	8.01	9.51
Other Current Assets	1.17	1.37	1.5	1.33	1.14
Total Current Assets	19.22	22.36	13.64	19.46	19.66
Net Property, Plant & Equipment	7.22	9.46	11.97	14.5	15.36
Goodwill	0.34	0.34	0.34	0.34	0.34
Other Long-Term Assets	0.21	0.2	0.19	0.02	0.02
Total Assets	26.99	32.34	26.13	34.31	35.38
Accounts Payable	6.9	4.25	5.8	5.33	2.87
Accrued Expenses	2.59	2.56	2.16	2.27	2.41
Current Portion of Leases	1.52	1.47	1.34	1.21	1.05
Unearned Revenue	8.83	15.44	12.09	12.78	11.07
Other Current Liabilities	0.08	0.14	0.15	0.15	0.07
Total Current Liabilities	19.92	23.85	21.54	21.73	17.48
Long-Term Leases	2.99	4.63	6.09	7.39	8.41
Other Long-Term Liabilities	0.01	0.09	0.4	0.55	0.39
Total Long-Term Liabilities	3	4.72	6.49	7.94	8.8
Total Liabilities	22.92	28.57	28.04	29.68	26.28
Common Stock	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-0.71	-0.71	-0.71	-0.07	-
Additional Paid-in Capital	85.7	84.36	83.38	82.01	81.06
Retained Earnings	-81.07	-79.89	-84.59	-77.32	-71.98
Total Common Shareholders' Equity	3.94	3.77	-1.9	4.64	9.1
Minority Interest	0.13	-	-	-	-
Shareholders' Equity	4.07	3.77	-1.9	4.64	9.1
Total Liabilities & Equity	26.99	32.34	26.13	34.31	35.38
Total Debt	4.51	6.11	7.43	8.6	9.47
Net Cash (Debt)	0.36	3.68	-4.81	1.52	-0.46
Net Cash Growth	-90.22%	-	-	-	-
Net Cash Per Share	0.03	0.26	-0.35	0.11	-0.03
Book Value	3.94	3.77	-1.9	4.64	9.1
Book Value Per Share	0.28	0.26	-0.14	0.34	0.64
Tangible Book Value	3.6	3.44	-2.24	4.3	8.76
Tangible Book Value Per Share	0.26	0.24	-0.17	0.32	0.62

SEC Filings: 10-K · 10-Q